"Is your gastroenterology service getting overwhelmed by the increasing number of referrals from primary care? Learn how Brian McKaig and his colleagues in Wolverhampton have come up with a solution to managing this challenge. And find out how Anjan Dhar and his colleagues in Durham have organised their service to provide effective care for their IBD patients whilst saving money.   

 The BSG are pleased to present this new permanent feature of service success stories from all round the country. The aim is to share experiences of how our colleagues have coped with challenges to the service and learn from each other. Our authors are happy to be contacted directly and to share details of what they did. We hope that you will find this useful.  

If you have a service success story that you would like to share, please contact me at tctham1234@gmail.com for further information. I am also happy to hear any comments that you may have about our feature."

Dr Tony Tham Chair, Clinical Services & Standards Committee


Stories we've received

Friday, 13 September 2019

The Development of a New Diagnostic Pathway to Detect Chronic Liver Disease across Primary and Secondary Care

The 'BSG Service Delivery Prize 2019' winning submission was from Dr Jane Chalmers and colleagues on behalf of the NIHR Nottingham Biomedical Research Centre for the development of a new diagnostic pathway to detect chronic liver disease across primary and secondary care.

Thursday, 18 July 2019

Computer says yes! - Intelligent Liver Function Testing: how an automated system can aid in diagnosis and staging of liver disease in primary care

This service success story has received innovation awards from the Royal College of Physicians and the Royal College of Pathologists.

Thursday, 28 March 2019

Royal Wolverhampton NHS Trust Gastroenterology Clinical Assessment Service

Thursday, 28 March 2019

Evidence based rational and cost-effective care for Inflammatory Bowel Disease patients managed with Biologics  

The aim of this initiative was to rationalise the use of high spend biologic drug treatments in IBD...